Page last updated: 2024-10-27

fenoldopam and Coronary Artery Disease

fenoldopam has been researched along with Coronary Artery Disease in 2 studies

Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.

Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pittarello, D1
Bonato, R1
Falasco, G1
Tiberio, I1
Gasparetto, M1
Ori, C1
Briguori, C1
Colombo, A1
Airoldi, F1
Violante, A1
Castelli, A1
Balestrieri, P1
Paolo Elia, P1
Golia, B1
Lepore, S1
Riviezzo, G1
Scarpato, P1
Librera, M1
Focaccio, A1
Ricciardelli, B1

Trials

2 trials available for fenoldopam and Coronary Artery Disease

ArticleYear
Effects of fenoldopam on myocardial function (strain rate) in patients with coronary artery disease undergoing cardiac surgery.
    Minerva anestesiologica, 2010, Volume: 76, Issue:9

    Topics: Aged; Antihypertensive Agents; Cardiac Surgical Procedures; Coronary Artery Disease; Female; Fenoldo

2010
N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity.
    Journal of the American College of Cardiology, 2004, Aug-18, Volume: 44, Issue:4

    Topics: Acetylcysteine; Administration, Oral; Aged; Contrast Media; Coronary Angiography; Coronary Artery Di

2004